Worth reading
25Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Conditional
How definitive the wording is.Who is moving to which position
Resolved 25 March 2026Incoming appointee
3 itemsScheduled Appointment DateEffective 1 April 2026 (certain titles to change). The scheduled date for the changes involving the Executive Officers is late June 2026, at the close of the 131st Annual General Meeting of Shareholders.
Mori Kenichi (茂利 憲一)
Previous positionExecutive Officer; General Manager, Global Business Division
New positionSenior Executive Officer; General Manager, Global Business Division
Takano Koichi (高野 浩一)
Previous positionGeneral Manager, General Affairs Department and Public Relations Office
New positionExecutive Officer; General Manager, Corporate Administration Division and Public Relations Office
Kamiya Tomoko (神谷 知子)
Previous positionDeputy General Manager, Healthcare Business Division
New positionExecutive Officer; General Manager, Healthcare Business Division
Departing officer
1 itemDate of departureLate June 2026, at the close of the 131st Annual General Meeting of Shareholders.
Sato Kimihiko (佐藤 公彦)Next role stated
Former PositionManaging Director; General Manager, Healthcare Business Division
New positionManaging Director responsible for the Healthcare Business Division
“Next role stated” means the document names the position the person holds after stepping down. It does not necessarily mean they are leaving the company.
Whether the incumbent will remain in office (whether they will retain their position)
Remains on the Board of Directors
Shareholders’ meeting approvalRequired. Scheduled to retire at the close of the 131st Annual General Meeting of Shareholders, which is scheduled to be held in late June 2026.
| Item | Details |
|---|---|
| Resolution date | 25 March 2026 |
| Scheduled Appointment Date | Effective 1 April 2026 (certain titles to change). The scheduled date for the changes involving the Executive Officers is late June 2026, at the close of the 131st Annual General Meeting of Shareholders. |
| Date of departure | Late June 2026, at the close of the 131st Annual General Meeting of Shareholders. |
| Name of appointee | Mori Kenichi (茂利 憲一), Takano Koichi (高野 浩一), Kamiya Tomoko (神谷 知子) |
| Appointee's new position | Senior Executive Officer; General Manager, Global Business Division, Executive Officer; General Manager, Corporate Administration Division and Public Relations Office, Executive Officer; General Manager, Healthcare Business Division |
| Appointee's previous position | Executive Officer; General Manager, Global Business Division, General Manager, General Affairs Department and Public Relations Office, Deputy General Manager, Healthcare Business Division |
| Name of departing officer | Sato Kimihiko (佐藤 公彦) |
| Former position of departing officer | Managing Director; General Manager, Healthcare Business Division |
| New position of departing officer | Managing Director responsible for the Healthcare Business Division |
| Whether the incumbent will remain in office | Remains on the Board of Directors |
| Subject to Approval by the General Meeting of Shareholders | Required. Scheduled to retire at the close of the 131st Annual General Meeting of Shareholders, which is scheduled to be held in late June 2026. |
Items this document does not state (10)
Appointee's date of birthYear the appointee joined the CompanyNumber of shares held by the appointeeReason for departureReason for changeReasons for appointmentNumber of directors after the changeFiling as an independent officerDetails of organizational changesChange in Corporate Governance Structure
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.No reason for the changes is provided.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.